AMRX logo

Amneal Pharmaceuticals (AMRX) Shareholders Equity

Annual Shareholders Equity

$19.78 M
-$278.64 M-93.37%

December 31, 2023


Summary


Performance

AMRX Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMRXbalance sheetmetrics:

Quarterly Shareholders Equity

-$93.43 M
-$35.97 M-62.59%

September 30, 2024


Summary


Performance

AMRX Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMRXbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

AMRX Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-93.4%-128.2%
3 y3 years-93.5%-129.4%
5 y5 years-96.1%-129.4%

AMRX Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-94.5%at low-123.9%at low
5 y5-year-94.5%at low-123.9%at low
alltimeall time-96.1%+105.1%-118.5%+75.8%

Amneal Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
-$93.43 M(+62.6%)
Jun 2024
-
-$57.47 M(-9.8%)
Mar 2024
-
-$63.72 M(-422.1%)
Dec 2023
$19.78 M(-93.4%)
$19.78 M(-94.0%)
Sep 2023
-
$330.86 M(+4.0%)
Jun 2023
-
$318.17 M(+8.1%)
Mar 2023
-
$294.41 M(-1.3%)
Dec 2022
$298.42 M(-17.2%)
$298.42 M(+0.3%)
Sep 2022
-
$297.47 M(+6.1%)
Jun 2022
-
$280.33 M(-28.3%)
Mar 2022
-
$391.13 M(+8.5%)
Dec 2021
$360.34 M
$360.34 M(+2.8%)
Sep 2021
-
$350.51 M(+1.3%)
DateAnnualQuarterly
Jun 2021
-
$346.11 M(+7.1%)
Mar 2021
-
$323.01 M(+6.5%)
Dec 2020
$303.27 M(+30.7%)
$303.27 M(+0.7%)
Sep 2020
-
$301.04 M(-1.6%)
Jun 2020
-
$306.00 M(-3.9%)
Mar 2020
-
$318.38 M(+37.2%)
Dec 2019
$232.01 M(-54.0%)
$232.01 M(+6.4%)
Sep 2019
-
$218.00 M(-52.6%)
Jun 2019
-
$459.66 M(-2.7%)
Mar 2019
-
$472.20 M(-6.4%)
Dec 2018
$504.75 M(-230.9%)
$504.75 M(+0.7%)
Sep 2018
-
$501.11 M(+1.3%)
Jun 2018
-
$494.50 M(-228.2%)
Dec 2017
-$385.74 M
-$385.74 M

FAQ

  • What is Amneal Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Amneal Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Amneal Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of AMRX is $19.78 M

What is the all time high annual shareholders equity for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual stockholders equity is $504.75 M

What is Amneal Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, AMRX annual stockholders equity has changed by -$278.64 M (-93.37%)

What is Amneal Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of AMRX is -$93.43 M

What is the all time high quarterly shareholders equity for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly stockholders equity is $504.75 M

What is Amneal Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, AMRX quarterly stockholders equity has changed by -$424.29 M (-128.24%)